Chemistry: molecular biology and microbiology – Micro-organism – per se ; compositions thereof; proces of... – Bacteria or actinomycetales; media therefor
Reexamination Certificate
2008-03-04
2008-03-04
Vogel, Nancy (Department: 1636)
Chemistry: molecular biology and microbiology
Micro-organism, per se ; compositions thereof; proces of...
Bacteria or actinomycetales; media therefor
C424S260100, C530S351000, C530S350000
Reexamination Certificate
active
07338794
ABSTRACT:
The present invention provides active cytokine and/or chemokine compositions, as well as inexpensive means for the production, amended-cell encasement of active cytokine and/or chemokine compositions, processing, and delivery of active cytokine and/or chemokine compositions. The subject invention also provides methods of treatment and methods of accelerating an immune response comprising the administration of amended recombinant cell (ARC) containing cytokine and/or chemokine compositions to animals or humans.
REFERENCES:
patent: 4432895 (1984-02-01), Tarnowski
patent: 4695455 (1987-09-01), Barnes et al.
patent: 4695462 (1987-09-01), Barnes et al.
patent: 5281532 (1994-01-01), Rammler et al.
patent: 6121247 (2000-09-01), Huang et al.
Steidler, L. (2002) “In situ delivery of cytokines by genetically engineeredLactococcus lactis” Antonie van Leeuwenhoek82:323-331.
Steilder, L. et al. (1998) “Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains foLactococcus lactiscoexpressing antigen and cytokine”Infection and Immunity66(7):3183-3189.
Carrier, M.J. et al. (1992) “Expression of human IL-1β inSalmonella typhimurium.A model system for the delivery of recombinant therapeutic proteins in vivo”J. Immunol.148(4):1176-1181.
Ada, G. et al. Overview of Host Defense Mechanisms with Special Reference to Viral Infections,Gamma Interferon in Antiviral Defense, 1997, pp. 1-18, Chapman & Hall, New. York.
Anderson, K.P. et al. “Enhancement Of a Secondary Antibody Response to Vesicular Stomatitis Virus ‘G’ Protein By IFN-Gamma Treatment at Primary Immunization”,J.Immunol., 1988, pp. 3599-3604, vol. 140, No. 10.
Babiuk, L.A. et al. “Application of Interferons In The Control of Infectious Diseases of Cattle”,Journal of Dairy Science, 1991, pp. 4385-4398, vol. 74, No. 12.
Cerretti, D.P., et al. “Cloning, Sequence, and Expression of Bovine Interferon-Gamma”,J.Immunol., 1986, pp. 4561-4564, vol. 136, No. 12.
Fox, L.K., et al. “The Effect Of Interferon-Gamma Intramammary Administration on Mammary Phagocyte Function”,J. Vet. Med B, 1990, pp. 28-30, vol. 37, Paul Parey Scientific Publishers, Berlin and Hamburg.
Fransen, L. et al. “Recombinant Tumor Necrosis Factor: Species Specificity For a Variety of Human and Murine Transformed Cell Lines”,Cell. Immunol., 1986, pp. 260-267, vol. 100.
Friedman, R.M. et al. “Interferons with Special Emphasis on the Immune System”,Adv. Immunol., 1983, pp. 97-140, Vol. 34.
Gaertner, F.H. et al. “CellCap: An Encapsulation System for Insecticidal Biotoxin Proteins”,Advanced Engineered Pesticides, 1993, pp. 73-83, Marcel Dekker, New York.
Gough, R.E., et al., “Further Studies On The Adjuvant Effect Of an Interferon Inducer (Brl-5907) on Newcastle Disease and Avian Influenza Inactivated Vaccines”,Res. Vet. Sci., 1975, pp. 185-188, vol. 19.
Gresser, I., et al. “Anti-Tumor Effects of Interferon In Mice Injected With Interferon-Sensitive and Interferon-Resistant Friend Leukemia Cells. VI. Adjuvant Therapy After Surgery in the Inhibition of Liver and Spleen Metastases”,Int. J. Cancer, 1987, pp. 789-792, vol. 39.
Knight Jr., E., “Antiviral and Cell Growth Inhibitory Activities Reside In The Same Glycoprotein Of Human Fibroblast Interferon”,Nature, 1976, pp. 302-303, vol. 262.
Lofthouse, S.A. et al. “Cytokines as Adjuvants For Ruminant Vaccines”,International Journal for Parasitology, 1996, pp. 835-842, vol. 26, No. 8/9.
Michalski, W.P. et al. “Recombinant Chicken IFN-Gamma Expressed InEscherichia coli: Analysis Of C-Terminal Truncation and Effect on Biologic Activity”,J. Interferon Cytokine Res., 1999, p. 383-392, vol. 19.
Opdenakker, G. et al. “Interaction of Interferon With Other Cytokines”,Experientia, 1989, pp. 513-520, vol. 45.
Perussia, B., et al. “Immune Interferon Induces The Receptor For Monomeric IgG1 on Human Monocytic and Myeloid Cells”,J. Exp. Med., 1983, pp. 1092-1113, vol. 158.
Pestka, S., et al. “Interferons and Their Actions”,Annu. Rev. Biochem., 1987, pp. 727-777, vol. 56.
Pighetti, G.M., et al. “Specific Immune Responses of Dairy Cattle After Primary Inoculation with Recombinant Bovine Interferon-Gamma as an Adjuvant When Vaccinating Against Mastitis”,American Journal of Veterinary Research, 1996, p. 819-824, vol. 57, No. 6.
Sordillo, L.M., et al. “Controlling AcuteEscherichia coliMastitis During the Periparturient Period with Recombinant Bovine Interferon-Gamma”,Veterinary Microbiology, 1991, pp. 189-198, vol. 28.
Steinbeck, M.J., et al. “Activation of Bovine Neutrophils By Recombinant Interferon-Gamma”,Cell. Immunol., 1986, pp. 137-144, vol. 98.
Vilcek, J., et al. “Interferon and the Immune System”,Interferon, 1984, vol. 2, Elsevier, Amsterdam.
Yilma, T.K. et al. “Expression of an Adjuvant Gene (Interferon-Gamma) in Infectious Vaccinia Virus Recombinants”,Vaccines 87: Modern Approaches to New Vaccines, 1987, pp. 393-396, Cold Spring Harbor, New York.
Yilma, T. et al. “Enhancement of Primary and Secondary Immune Responses By Interferon-Gamma”,Adv.Exp.Med.Biol.1989, pp. 145-152, vol. 251.
Yip, Y.K., et al. “Purification and Structural-Functional Characterization of Human Immune Interferon”,J. Biol. Chem., 1984, p. 283, vol. 3.
Zuffa, A. et al. “Protection of Cattle Vaccinated With Inactivated Oil Adjuvant Infectious Bovine Rhino Tracheitis Vaccine Against Experimental Infection”,Zbl. Vet. Med. B., 1980, pp. 725-733, vol. 27.
Gaertner Frank H.
Lee Stacey Lynn
Shutter Robert W.
Dow AgroSciences LLC
Saliwanchik Lloyd & Saliwanchik
Vogel Nancy
LandOfFree
Amended recombinant cells for the production and delivery of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amended recombinant cells for the production and delivery of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amended recombinant cells for the production and delivery of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2805505